SCHEMBL2447313

SCHEMBL2447313

Cc1cc(/C=N\O)cc(C)c1OCC1CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.39
HTT P42858 5/20 0.39
SMN1; SMN2 Q16637 5/20 0.39
PPARG P37231 2/20 0.39
PPARD Q03181 2/20 0.39
HSD17B10 Q99714 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
PKM P14618 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPK1 P28482 1/20 0.38
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
HPGD P15428 4/20 0.36
MAPT P10636 2/20 0.36
POLB P06746 1/20 0.35
PPARA Q07869 1/20 0.35
LMNA P02545 2/20 0.35
NPC1 O15118 1/20 0.34
CASP3 P42574 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2447314 1.00 ALDH1A1 (0.39) ALDH1A1HTTSMN1; SMN2PPARGPPARD
SCHEMBL2007212 0.79 SRC (0.45) ALDH1A1PPARGPPARDHPGDPPARA
SCHEMBL2449843 0.78 ALDH1A1 (0.59) ALDH1A1HTTSMN1; SMN2HSD17B10CYP1A2
SCHEMBL2449841 0.78 ALDH1A1 (0.59) ALDH1A1HTTSMN1; SMN2HSD17B10CYP1A2
SCHEMBL14943724 0.76 HTR1A (0.42) ALDH1A1PPARGPPARDMEN1KMT2A
SCHEMBL2443371 0.72 ALDH1A1 (0.49) ALDH1A1HTTSMN1; SMN2HSD17B10CYP1A2
SCHEMBL2009598 0.72 ALDH1A1 (0.49) ALDH1A1HTTSMN1; SMN2HSD17B10CYP1A2
SCHEMBL2009596 0.72 ALDH1A1 (0.49) ALDH1A1HTTSMN1; SMN2HSD17B10CYP1A2
SCHEMBL12401804 0.71 RIPK1 (0.39) PPARGPPARDCYP1A2CYP2C19POLB
SCHEMBL14877969 0.70 KMT2A (0.43) ALDH1A1PPARGPPARDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 EP disclosed